← Open Payments lookup

ARKADIY CHERNYAK: Open Payments

NPI 1780733147 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$380 in 26 payments from 7 companies in 2025. Trend: 2023 $125 · 2024 $246 · 2025 $380

Food & beverage: $380
CompanyPaymentsAmount
ABBVIE INC.16$206
Teva Pharmaceuticals USA, Inc.5$89
Neurocrine BioSciences, Inc.1$20
E.R. Squibb & Sons, L.L.C.1$18
Novo Nordisk Inc1$18
Otsuka America Pharmaceutical, Inc.1$16
Takeda Pharmaceuticals U.S.A., Inc.1$14

Products named: VRAYLAR, AUSTEDO XR, INGREZZA, COBENFY, Rybelsus, REXULTI, TRINTELLIX.

Industry payments across NJ — which companies pay providers there.